Pfizer Inc. will not seek emergency authorization of its coronavirus vaccine any earlier than the third week in November, when it projects it will hit important testing milestones, the company’s CEO said Friday.
Join the fight for freedom
Be the first to know: Stories from The Washington Informer in your inbox each weekday.